Prenetics Global Limited
NASDAQ Global MarketTotal Valuation
Prenetics Global Limited carries a market capitalization of 224.78M, placing it among publicly traded companies globally. Its enterprise value stands at -108.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 224.78M |
| Enterprise Value | -108.51M |
Share Statistics
Prenetics Global Limited currently has 15.06M shares outstanding.
| Shares Outstanding | 15.06M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Prenetics Global Limited maintains a current ratio of 4.04, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.73, indicating moderate leverage, while an interest coverage ratio of -509.44 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.04 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -509.44 |
Financial Efficiency
| Return on Equity (ROE) | -38.52 |
| Return on Assets (ROA) | -26.64 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.85 |
Taxes
| Income Tax | 80,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Prenetics Global Limited's stock has declined approximately -74.19355% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -74.19355% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -50.94M, while operating income came in at -51.32M.
| Revenue | 142.56M |
| Gross Profit | 89.10M |
| Operating Income | -51.32M |
| Pretax Income | -52.83M |
| Net Income | -47.00M |
| EBITDA | -50.94M |
| EBIT | -51.32M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Prenetics Global Limited holds 109.39M in cash and equivalents against 682,000.00 in total debt, resulting in a net debt position of -59.05M. Total book value stands at 93.01M, with working capital of 111.12M providing operational flexibility.
| Cash & Cash Equivalents | 109.39M |
| Total Debt | 682,000.00 |
| Net Debt | -59.05M |
| Equity (Book Value) | 93.01M |
| Book Value Per Share | 6.18 |
| Working Capital | 111.12M |
Cash Flow
Prenetics Global Limited produced -27.92M in operating cash flow over the past twelve months.
| Operating Cash Flow | -27.92M |
| Capital Expenditures | N/A |
| Free Cash Flow | -27.92M |
| FCF Per Share | N/A |
Margins
Prenetics Global Limited operates with a gross margin of 62.50, reflecting its pricing power and cost economics. The operating margin of -36.00 and net profit margin of -32.97 provide insight into operational efficiency.
| Gross Margin | 62.50 |
| Operating Margin | -36.00 |
| Pretax Margin | -37.06 |
| Profit Margin | -32.97 |
| EBITDA Margin | -35.74 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 12,305.73 |
| FCF Yield | N/A |
Scores
Prenetics Global Limited posts an Altman Z-Score of 0.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.70 |